We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Awareness Technology Announces Availability of Two-Plate ELISA and Chemiluminescent Analyzer

By LabMedica International staff writers
Posted on 15 Jun 2020
Print article
Image: Chemwell 2 ELISA Chemiluminescent Chemistry Analyzer (Photo courtesy of Awareness Technology, Inc.)
Image: Chemwell 2 ELISA Chemiluminescent Chemistry Analyzer (Photo courtesy of Awareness Technology, Inc.)
Awareness Technology, Inc. (Palm City, Florida, USA) has announced the availability of ChemWell 2, its two-probe, two-plate automatic combo analyzer for ELISA and chemiluminescent (CLIA).

Awareness Technology, an international IVD company, develops, manufactures, and markets in-vitro diagnostic instrumentation and diagnostic test kits, including biochemistry, ELISA, chemiluminescence, imaging analytics, electrolyte instruments, and supportive equipment. The company’s test kit portfolio includes ELISA kits for autoimmune and infectious disease testing, biochemistry test kits (for export only), allergy screening products, and instrument QC verification materials.

For 20 years, the company has produced single plate ChemWell automatic ELISA and CLIA systems with the flexibility to run both modes simultaneously even within the same plate. With laboratories expanding serology requirements, the two-plate system is expected to be a more suitable primary instrument for lower throughput labs, and ideal for off-line assays in higher throughput settings.

The key to automating a wide variety of unrelated test methods is ChemWell’s flexibility in both hardware and software. Separate probes are used for samples and reagents with an option for disposable tips. Filters range from 405 nm – 630 nm; dispense volume from 2µL to 1.95 ml; plate washing routines, temperature control, and mixing are programmable. Intuitive software offers on-board pre-dilutions, multiple calibration options, replicates, statistics, QC tracking, bar-coded sample ID and data management. It even schedules assays to prevent timing conflicts while providing optimal throughput. An optional laptop stand conserves bench space.


Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Aspergillus Test
REALQUALITY Aspergillus
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.